175 related articles for article (PubMed ID: 10777605)
1. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
Vaisman A; Chaney SG
J Biol Chem; 2000 Apr; 275(17):13017-25. PubMed ID: 10777605
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
3. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
4. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
5. The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts.
Vaisman A; Warren MW; Chaney SG
J Biol Chem; 2001 Jun; 276(22):18999-9005. PubMed ID: 11259423
[TBL] [Abstract][Full Text] [Related]
6. Specificity of platinum-DNA adduct repair.
Chaney SG; Vaisman A
J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
[TBL] [Abstract][Full Text] [Related]
7. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
8. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
Havener JM; Nick McElhinny SA; Bassett E; Gauger M; Ramsden DA; Chaney SG
Biochemistry; 2003 Feb; 42(6):1777-88. PubMed ID: 12578393
[TBL] [Abstract][Full Text] [Related]
9. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
10. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
[TBL] [Abstract][Full Text] [Related]
11. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
Vaisman A; Varchenko M; Umar A; Kunkel TA; Risinger JI; Barrett JC; Hamilton TC; Chaney SG
Cancer Res; 1998 Aug; 58(16):3579-85. PubMed ID: 9721864
[TBL] [Abstract][Full Text] [Related]
12. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
[TBL] [Abstract][Full Text] [Related]
13. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
14. Effects of base sequence context on translesion synthesis past a bulky (+)-trans-anti-B[a]P-N2-dG lesion catalyzed by the Y-family polymerase pol kappa.
Huang X; Kolbanovskiy A; Wu X; Zhang Y; Wang Z; Zhuang P; Amin S; Geacintov NE
Biochemistry; 2003 Mar; 42(8):2456-66. PubMed ID: 12600213
[TBL] [Abstract][Full Text] [Related]
15. Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesis.
Maga G; Villani G; Ramadan K; Shevelev I; Tanguy Le Gac N; Blanco L; Blanca G; Spadari S; Hübscher U
J Biol Chem; 2002 Dec; 277(50):48434-40. PubMed ID: 12368291
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
Ouzon-Shubeita H; Baker M; Koag MC; Lee S
Biochem J; 2019 Feb; 476(4):747-758. PubMed ID: 30709915
[TBL] [Abstract][Full Text] [Related]
17. Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases.
Choi JY; Chowdhury G; Zang H; Angel KC; Vu CC; Peterson LA; Guengerich FP
J Biol Chem; 2006 Dec; 281(50):38244-56. PubMed ID: 17050527
[TBL] [Abstract][Full Text] [Related]
18. Versatility of Y-family Sulfolobus solfataricus DNA polymerase Dpo4 in translesion synthesis past bulky N2-alkylguanine adducts.
Zhang H; Eoff RL; Kozekov ID; Rizzo CJ; Egli M; Guengerich FP
J Biol Chem; 2009 Feb; 284(6):3563-76. PubMed ID: 19059910
[TBL] [Abstract][Full Text] [Related]
19. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
[TBL] [Abstract][Full Text] [Related]
20. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
Yang J; Parsons J; Nicolay NH; Caporali S; Harrington CF; Singh R; Finch D; D'Atri S; Farmer PB; Johnston PG; McKenna WG; Dianov G; Sharma RA
Oncogene; 2010 Jan; 29(3):463-8. PubMed ID: 19838217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
